Compare Revvity Inc (RVTY) vs Spotify Technology (SPOT) Price & Performance

Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.

The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.

Spotify (SPOT) trades at $526.42, up 2.63% with strong technical momentum. The stock shows robust fundamental improvement with revenue growing from $11.7B in 2022 to $17.2B in 2025, while net income turned positive reaching $2.2B. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains overwhelmingly positive with 62% buy ratings and a $606.50 consensus target.

The outlook remains favorable with continued revenue growth and margin expansion driving profitability. Key risks include competitive pressures in streaming and execution challenges. With strong institutional support and improving cash flow generation, SPOT presents a compelling growth story, though investors should monitor Q3 2026 earnings due October 22 for confirmation of the positive trajectory.